# Duragen® Secure Post Marketing Clinical Follow-up (PMCF)

> **NCT02225080** · — · COMPLETED · sponsor: **Integra LifeSciences Corporation** · enrollment: 100 (actual)

## Conditions studied

- Dura Mater Nick Cut or Tear
- Surgery

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02225080
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02225080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02225080, "Duragen® Secure Post Marketing Clinical Follow-up (PMCF)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02225080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*